» Articles » PMID: 17284523

Altered Dynamics of the Lysosomal Receptor for Chaperone-mediated Autophagy with Age

Overview
Journal J Cell Sci
Specialty Cell Biology
Date 2007 Feb 8
PMID 17284523
Citations 104
Authors
Affiliations
Soon will be listed here.
Abstract

Rates of autophagy, the mechanism responsible for lysosomal clearance of cellular components, decrease with age. We have previously described an age-related decline in chaperone-mediated autophagy (CMA), a selective form of autophagy, by which particular cytosolic proteins are delivered to lysosomes after binding to the lysosome-associated membrane protein type 2A (LAMP-2A), a receptor for this pathway. Rates of CMA decrease with age because of a decrease in the levels of LAMP-2A. In this work we have investigated the reasons for the reduced levels of LAMP-2A with age. While transcriptional rates of LAMP-2A remain unchanged with age, the dynamics and stability of the receptor in the lysosomal compartment are altered. The mobilization of the lysosomal lumenal LAMP-2A to the membrane when CMA is activated is altered in lysosomes from old animals, leading to the presence of an unstable pool of lumenal LAMP-2A. By contrast, the regulated cleavage of LAMP-2A at the lysosomal membrane is reduced owing to altered association of the receptor and the protease responsible for its cleavage to particular membrane microdomain regions. We conclude that age-related changes at the lysosomal membrane are responsible for the altered turnover of the CMA receptor in old organisms and the consequent decline in this pathway.

Citing Articles

Sex-specific and cell-type-specific changes in chaperone-mediated autophagy across tissues during aging.

Khawaja R, Martin-Segura A, Santiago-Fernandez O, Sereda R, Lindenau K, McCabe M Nat Aging. 2025; .

PMID: 39910244 DOI: 10.1038/s43587-024-00799-6.


Chaperone-mediated autophagy as a modulator of aging and longevity.

Endicott S Front Aging. 2024; 5:1509400.

PMID: 39687864 PMC: 11647017. DOI: 10.3389/fragi.2024.1509400.


Targeting chaperone-mediated autophagy in neurodegenerative diseases: mechanisms and therapeutic potential.

Wu J, Xu W, Su Y, Wang G, Ma J Acta Pharmacol Sin. 2024; .

PMID: 39548290 DOI: 10.1038/s41401-024-01416-3.


Selective protein degradation through chaperone‑mediated autophagy: Implications for cellular homeostasis and disease (Review).

Huang J, Wang J Mol Med Rep. 2024; 31(1).

PMID: 39513615 PMC: 11542157. DOI: 10.3892/mmr.2024.13378.


Expression of Autophagy Markers LC3B, LAMP2A, and GRP78 in the Human Kidney during Embryonic, Early Fetal, and Postnatal Development and Their Significance in Diabetic Kidney Disease.

Brdar I, Racetin A, Jelicic I, Vukojevic K, Vuckovic L, Ljutic D Int J Mol Sci. 2024; 25(17).

PMID: 39273100 PMC: 11394701. DOI: 10.3390/ijms25179152.